Cell and Gene Therapy CDMO Solutions

With global contract development and manufacturing (CDMO) facilities serving clients with plasmid DNA, viral vector, and cell therapy manufacturing, we have supported the development of 24 FDA-approved cell and gene therapies and have conducted more than 1,000 studies in this field over the past year. Our integrated approach combines R&D with CMC and biologics testing to maximize knowledge transfer, reduce bottlenecks, and accelerate drug developments to help you achieve your critical development goals faster, from discovery to commercialization.

Consult an expert

Pharmaceutical technicians in cleanroom at Cell and Gene Therapy CDMO facility in Memphis

Explore our Cell and Gene Therapy Manufacturing Services and Products

Plasmid DNA Manufacturing Services

Phase-appropriate custom plasmid production from research to High Quality and GMP grade, supporting all stages of clinical development through to commercial supply.

Viral Vector Manufacturing Services

Development and scaled GMP manufacturing solutions for AAV, lentiviral vector, adenovirus, and retrovirus-based gene and gene-modified cell therapies.

Cell Therapy CDMO Services

Analytical and process development, and CGMP cell therapy manufacturing services of autologous & allogeneic T-cells, NKs, dendritic cells, MSCs, HSCs, and more.

Off-the-Shelf Plasmid Products

Premium portfolio of off-the-shelf plasmid products to enhance and streamline gene therapy research and discovery programs.

Viral Vector Packaging Services

Customizable AAV packaging at multiple scales for every phase of research, and custom lentiviral packaging for HQ and GMP grades.

CAR-T Manufacturing

Accelerate your CAR-T manufacturing program with a therapeutic development process built on quality, with custom assays, regulatory compliance, and robust manufacturing processes.

Quality and Regulatory Services

Our CDMO Center of Excellence in Memphis cleared back-to-back inspections by the European Medicines Agency and the Food and Drug Administration Center for Biologics Evaluation and Research.

Manufacturing Platforms

Our CDMO teams have established proven production platforms to support streamlined plasmid DNA, viral vector, and CAR-T therapy manufacture with industry-leading timelines.

Oncology Manufacturing

Choose an oncology CDMO that removes complexity so you can advance therapies with confidence.

Talk to the team

Photo of the exterior of the Alderley Park, UK Cell and Gene Therapy CDMO Facility

Cell and Gene Therapy CDMO Facilities

Accelerate the development of your product and ensure it meets the highest regulatory standards while maintaining efficient production timelines through our integrated global network of contract development and manufacturing organization (CDMO) facilities and testing sites.

Explore our Sites

Cell and gene therapy developers in the laboratory

CGT Incubator and Accelerator Programs

Jumpstarting promising ideas and enhancing access for early-stage cell and gene therapy developers; register your interest in taking part in the next cohort.

Learn More

Cell and Gene therapy summit logo of a pin drop with mountains.

2025 Cell and Gene Therapy Summit

Explore key takeaways from the 2025 Cell and Gene Therapy Summit, including expert insights, patient stories, market trends, and exclusive interviews on the future of advanced therapies. 

Explore Event Resources

Charles River lab technician working at computer

Resource Hub: CGT Manufacturing Scale Up

Committed to accelerating the manufacture of life-changing cell and gene therapies to improve patient access, we have consolidated expert resources to help scale up your program.

Get Expert Advice

Charles River lab technician working at computer

A Commitment to Manufacturing Excellence

Advance your program with confidence and enhance manufacturing efficiency, quality, and compliance, because every moment matters on the path from concept to cure.

Learn How

 

Upcoming Webinar

View All Events